Chang Sharon, Brooke Magdalene, Cureton Elizabeth, Yeh Alice, Chen Rhona, Mazzetti-Barros Nicole, Rahbari Reza, Butler Sherry, Hill Nicole, Shim Veronica
Department of Surgery, Fremont Medical Center, CA.
Department of Surgery, University of California, San Francisco East Bay.
Perm J. 2019;23. doi: 10.7812/TPP/18-073. Epub 2019 Jun 14.
Preoperative wire localization (WL), the most common localization technique for nonpalpable breast lesions, has drawbacks including scheduling constraints, cost, and patient discomfort.
To reduce WL use in our health care system, we investigated using hydrogel clips to facilitate intraoperative ultrasonography-guided lumpectomies.
We retrospectively reviewed electronic medical records of patients with nonpalpable, ultrasound-visible breast lesions who underwent lumpectomy by 7 surgeons at 4 pilot sites in Kaiser Permanente Northern California between January 2015 and October 2015. Hydrogel clips, used for several years before the study period, were placed routinely during core-needle biopsy in all patients with nonpalpable, ultrasound-visible breast lesions.
Localization method, lesion size, margin positivity, and receipt of neoadjuvant therapy.
One hundred forty-three patients underwent hydrogel clip placement and lumpectomy by pilot-site surgeons. Localization consisted of intraoperative ultrasonography alone, preoperative skin marking, or WL. Of the 143 patients, 71.3% did not need WL (60.8% ultrasonography alone and 10.5% skin marking). The non-WL and WL groups had similarly sized lesions, and the positive margin rate was 7.2% overall, with no significant difference between the non-WL and WL groups (5.9% vs 11.5%, p = 0.33). Of the 12 patients who underwent neoadjuvant chemotherapy, 8 (67%) did not require WL.
A multifacility protocol using intraoperative ultrasonography to visualize hydrogel clips was implemented, which decreased WL procedures and produced no significant difference in margin positivity between the WL and non-WL groups. This technique can be a cost-effective alternative to WL in patients who are candidates for hydrogel clip placement.
术前金属丝定位(WL)是不可触及乳腺病变最常用的定位技术,但其存在包括时间安排受限、费用以及患者不适等缺点。
为减少我们医疗系统中WL的使用,我们研究了使用水凝胶夹来辅助术中超声引导下的乳房肿瘤切除术。
我们回顾性分析了2015年1月至2015年10月期间在北加利福尼亚州凯撒医疗集团4个试点机构由7名外科医生为不可触及、超声可见乳腺病变患者实施乳房肿瘤切除术的电子病历。在研究期间之前已使用数年的水凝胶夹,在所有不可触及、超声可见乳腺病变患者的粗针活检过程中常规放置。
定位方法、病变大小、切缘阳性情况以及新辅助治疗的接受情况。
143例患者由试点机构的外科医生进行了水凝胶夹放置及乳房肿瘤切除术。定位方式包括单纯术中超声、术前皮肤标记或WL。在这l43例患者中,71.3%不需要WL(60.8%单纯超声定位,10.5%皮肤标记)。非WL组和WL组病变大小相似,总体切缘阳性率为7.2%,非WL组和WL组之间无显著差异(5.9%对11.5%,P=0.33)。在接受新辅助化疗的12例患者中,8例(67%)不需要WL。
实施了一项多机构方案,使用术中超声来观察水凝胶夹,这减少了WL操作,且WL组和非WL组之间切缘阳性情况无显著差异。对于适合放置水凝胶夹的患者,该技术可为WL提供一种经济有效的替代方法。